top of page
The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in New Jersey in 2022.
Economic
Output
$120.9B
Direct Jobs Supported by the Industry
75,833
Total Jobs Supported
356,725
State Total Vendor Relationships
4,281
State Total Vendor Spending
$6,601,301,465
Clinical
Trials
792
Investments at Clinical Trial Sites
$320.4M
Clinical Trial Participants
16,649
Total Economic Impact of Clinical Trial Sites
$879.7M
bottom of page